Cath Lab

The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).

Building on the award-winning Allia platform for image guided therapies, GE HealthCare's new Allia IGS Pulse was designed to improve workflow for the diagnosis and treatment of cardiovascular diseases in interventional cardiology. (Photo: Business Wire) 
News | Cath Lab
GE HealthCare Receives FDA Clearance of Allia IGS Pulse - the Next Generation of Image-Guided Systems Designed for Cardiac Imaging Excellence

October 16, 2023 — GE HealthCare (Nasdaq: GEHC) announced US FDA 510(k) clearance of Allia IGS Pulse - the latest ...

Home October 16, 2023
Home
Shimadzu Medical Systems USA, a subsidiary of Shimadzu Corporation, announced the first U.S. installation of a Trinias SCORE Opera C12 (ceiling mounted cutting edge angiography system) at Beaufort Memorial Hospital (Beaufort, SC).
News | Cath Lab
Shimadzu Medical Systems USA Installs First Trinias Score Opera Cardiac Catheterization Lab in the US

October 16, 2023 — Shimadzu Medical Systems USA, a subsidiary of Shimadzu Corporation, announced the first U.S ...

Home October 16, 2023
Home
University Hospitals Harrington Heart & Vascular Institute first to adopt technology in U.S.
News | Cath Lab
New Study Confirms HeartFlow FFRCT Leads to Improved Patient Outcomes

September 13, 2023 — A diagnostic test, first offered in the United States at University Hospitals (UH) Harrington Heart ...

Home September 13, 2023
Home
The global interventional cardiology device market is driven by the number of procedures performed across the globe
Feature | Cardiovascular Business | By Emily Gilbert and Kamran Zamanian, PhD
The New Interventional Cardiology Market

The global interventional cardiology device market is driven by the number of procedures performed across the globe. The ...

Home September 12, 2023
Home
UCLA-led research finds that among adult congenital heart disease (CHD) transplant recipients, single-ventricle physiology correlated with higher short-term mortality
News | Congenital Heart
UCLA Research Suggests that Heart Transplantation is Safer for Adults with Single-ventricle CHD than Previously Thought

September 12, 2023 — UCLA-led research finds that among adult congenital heart disease (CHD) transplant recipients ...

Home September 12, 2023
Home
Here's a look at what viewers found most interesting during the month of August on dicardiology.com
Feature | Cardiovascular Business | By Melinda Taschetta-Millane
Top 10: A Look at the Hot Topics from August

As we wind down the summer months, DAIC takes a look at the Top 10 most-read pieces of content from www.dicardiology.com ...

Home August 31, 2023
Home
STOPDAPT-3 trial presented in a Hot Line Session Saturday at ESC Congress 2023
News | Antiplatelet and Anticoagulation Therapies
Dual-antiplatelet Therapy Should Remain Standard Strategy After Stent Implantation

August 28, 2023 — Prasugrel monotherapy after percutaneous coronary intervention (PCI) with drug-eluting stents is not ...

Home August 28, 2023
Home
CVi screenshot
Blog | Contrast Media Injectors
BLOG: Enhancing Efficiency and Patient Care with a Modern Injector

Adjustable parameters on the ACIST® CVI® Contrast Delivery System include, flow rate, volume, pressure limit, rise time ...

Home August 22, 2023
Home
As medical advancements continue to push the boundaries of what is possible in the field of structural heart interventions, the importance of enterprise imaging has become increasingly evident.
Blog | Enterprise Imaging
BLOG: The Power of Enterprise Imaging in Structural Heart Procedures

As medical advancements continue to push the boundaries of what is possible in the field of structural heart ...

Home August 10, 2023
Home
The 510(k) application covers Evie Ring’s pulse oximeter that includes heart rate and SpO2 data, and is expected to make it one of the first consumer wearables that is also cleared for clinical use
News | Wearables
Biosense Webster Receives FDA Approval for Multiple Atrial Fibrillation Ablation Products to be Used in a Workflow Without Fluoroscopy

August 7, 2023 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson M ...

Home August 07, 2023
Home
the U.S Food and Drug Administration (FDA) has cleared the QuikClot Control+ Hemostatic Device to include mild and moderate bleeding in cardiac surgical procedures and bone surface bleeding following a sternotomy
News | Cath Lab
Teleflex Receives FDA Clearance for Expanded Indication for QuikClot Control+ Hemostatic Device Usage in Cardiac Surgical Procedures

August 2, 2023 — Teleflex Incorporated, a leading global provider of medical technologies, announced the U.S Food and ...

Home August 02, 2023
Home
Here is a look at what DAIC viewers were reading during the month of July
Feature | Cardiovascular Business | By Melinda Taschetta-Millane
What Viewers Were Reading in July

Here is a look at what DAIC viewers were reading during the month of July:


1. Lessons Learned from World’s First ...

Home August 01, 2023
Home
Abbott is recalling the Amplatzer Steerable Delivery Sheath due to an increased risk for air emboli to be introduced into patients who have procedures with this device.
News | Left Atrial Appendage (LAA) Occluders
Abbott Recalls Amplatzer Steerable Delivery Sheath for Increased Risk of Air Embolism

July 26, 2023 — Abbott is recalling the Amplatzer Steerable Delivery Sheath due to an increased risk for air emboli to ...

Home July 26, 2023
Home
Under the agreement, BIS will initiate the US commercialization activities for ŌNŌCOR’s ŌNŌ Retrieval Device.
News | Cardiovascular Business
ŌNŌCOR signs an exclusive US distribution agreement with B. Braun Interventional Systems

July 26, 2023 —ŌNŌCOR LLC, a medical technology company dedicated to developing essential safety tools and other ...

Home July 26, 2023
Home
SmartfIRE study is evaluating THERMOCOOL SMARTTOUCH SF Dual Energy Catheter’s potential to enable safe and simple procedures with the ability to deliver both radiofrequency (RF) and pulsed field ablation (PFA)
News | Atrial Fibrillation
Biosense Webster Completes Enrollment in Pivotal Trial Evaluating PFA and RF Dual Energy Catheter for Patients with Atrial Fibrillation in Europe

July 21, 2023 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson ...

Home July 21, 2023
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now